Medtronic's Ishrak predicts deeper payer/provider integration; Patients want their device implant data;

 @MarkHFierce: Folks, there's still time to submit your nominations for the FierceMedicalDevices Fierce 15 private device developers. Survey | Follow @MarkHFierce

> Even though many doctors now doubt the effectiveness of PSA tests to screen men for prostate cancer, they'll keep doing them because of patient preference, according to a new survey. Blog

> Medtronic ($MDT) CEO Omar Ishrak says he expects payer/provider integration in the U.S. healthcare system regardless of the Supreme Court ruling on the national health reform law. Story

> Scientists at Imperial College London and the University of Vigo have developed an ultra-sensitive diagnostic test designed to detect signs of a disease at its earlier stages. Release

> The FDA is planning a series of public forums for later this year to boost quality promotion for device manufacturers. Among the events planned is the agency's annual FDA Inspections Summit, from Sept. 19-21 in Bethesda, MD. Story

> Surgeons are increasingly using next-generation surgical robots to perform precise, detailed surgeries. Story

Biotech News

 @FierceBiotech: 23andMe stakes a claim on Parkinson's gene. More | Follow @FierceBiotech

 @RyanMFierce: Which data analysis provider does Vertex blame for misinterpreting CF results? Seems like a big dropped ball. | Follow @RyanMFierce

 @JohnCFierce: Phase III starts in June: Sanofi/Regeneron add to stockpile of promising PCSK9 LDL drug data. Item | Follow @JohnCFierce

> Bungled analysis forces Vertex to revise cystic fibrosis drug data. News

> Lilly backs $150M Montreal biotech fund for single-project startups. Story

> Insider accounts spur a reported bidding war for Amylin. Article

> Senator takes a stab at repeating biotech R&D credit program. More

Pharma News

 @FiercePharma: Remember that U.K. recall where Seroquel packs got into boxes of a popular painkiller? The perp is in jail for 18 months. Story | Follow @FiercePharma

> Big Pharma sweats outcome of Supreme Court ruling. Report

> Teva says no thank you to generic Lipitor. News

> Roche tightens credit for long-past-due hospitals in Spain, Portugal. Item

> Sanofi, Merck reportedly place bids for Amylin. Article

Pharma Manufacturing News

> Drug shortages deepen as Pakistan debates price controls. Story

> Ranbaxy hires U.S. consultants under consent decree. Report

> Hospira overfills far greater than first thought. More

> As manufacturing capacity halves, CMO revenue could double in Europe. Analysis

Biotech IT News

> BGI and Big Pharma probe trigger of liver cancer. Article

> 23andMe stakes a claim on Parkinson's gene. Item

> Roche re-enlists software for personalized medicine research. News

> Broken link found in electronic clinical trial startups. Report

Biotech Research News

> Scientists decipher how T cells hunt down infection. Story

> Embyronic stem cells treat neuropathic pain in preclinical success. More

> New peptide compound triggers enhanced tumor cell death. News

> Dangerous antipsychotic shows leukemia-fighting promise in mice. Article

And Finally... National Public Radio reports on efforts by patients with implants, like ICDs, to obtain data about their devices, how they are working and what the machines are picking up. Companies, such as Medtronic, say they are willing, but need to figure out how to format the raw data so it is useful and patients can understand it. Story

Suggested Articles

The ADDF announced its second round of research awards, with a total of $6 million in new funding for diagnostic tests.

Takeda teamed up with Enzyre to develop an at-home diagnostic device that will help people with hemophilia determine their own coagulation status.

Foundation Medicine received a diagnostic approval from the FDA for selecting HR+/HER2- breast cancer patients for treatment with Novartis' Piqray.